Ginkgo Bioworks (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ginkgo Bioworks" in English language version.

refsWebsite

Global rank English rank

15web.archive.org

1^st place

3forbes.com

54^th place

48^th place

3reuters.com

49^th place

47^th place

3yahoo.com

38^th place

40^th place

2newspapers.com

55^th place

36^th place

2tipranks.com

low place

1sec.gov

572^nd place

436^th place

1wired.com

193^rd place

152^nd place

1bostonglobe.com

553^rd place

334^th place

1cnbc.com

220^th place

155^th place

1startupsavant.com

low place

1ginkgobioworks.com

low place

1investorplace.com

low place

1prnewswire.com

406^th place

258^th place

1genengnews.com

low place

6,625^th place

1bloomberg.com

99^th place

77^th place

1archive.today

14^th place

1biospace.com

low place

7,595^th place

1seekingalpha.com

5,344^th place

3,420^th place

1technologyreview.com

1,943^rd place

1,253^rd place

1businesswire.com

615^th place

407^th place

archive.today

Griffin, Riley (17 October 2022). "Ginkgo Is Trying to Detect Future Man-Made Biological Threats". Bloomberg News. Archived from the original on 18 October 2022.

biospace.com

Doctor, Vanessa (7 October 2021). "Ginkgo Bioworks Hit After Short Seller Claims Business Model a 'Shell Game'". Biospace. Retrieved 14 March 2024.

bloomberg.com

Griffin, Riley (17 October 2022). "Ginkgo Is Trying to Detect Future Man-Made Biological Threats". Bloomberg News. Archived from the original on 18 October 2022.

bostonglobe.com

Weisman, Robert (29 September 2016). "Ginkgo Bioworks opens production site for custom cells". Boston Globe. Retrieved 4 December 2017.

businesswire.com

"GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ginkgo Bioworks Holdings, Inc. - DNA". BusinessWire. 25 March 2023. Retrieved 14 March 2024.

cnbc.com

de León, Riley (17 September 2021). "Ginkgo Bioworks begins trading on the NYSE after completing SPAC merger". CNBC. Archived from the original on 17 September 2021. Retrieved 17 September 2021.

forbes.com

Herper, Mathew (8 June 2016). "Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry". Forbes. Archived from the original on 9 Jun 2016. Retrieved 4 December 2017.
Adams, Susan (14 September 2017). "Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer". Forbes. Archived from the original on 5 December 2017. Retrieved 4 December 2017.
Saul, Derek (25 July 2022). "Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million". Forbes.

genengnews.com

LeMieux, Julianna (5 October 2022). "Two Is Better Than One: Ginkgo Bioworks Acquires Altar and Circularis". Genetic Engineering and Biotechnology News. Archived from the original on 5 October 2022. Retrieved 5 October 2022.

ginkgobioworks.com

"Taking Ginkgo Public on NYSE:DNA". Ginkgo Bioworks. 14 May 2021. Archived from the original on 15 May 2021. Retrieved 15 May 2021.

investorplace.com

Pan, Eddie (7 April 2022). "Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here's Why". InvestorPlace. Archived from the original on 12 October 2022. Retrieved 21 December 2022.

newspapers.com

Kirsner, Scott (24 July 2015). "Dollars and scents". Boston Globe. pp. C4. Retrieved 23 December 2022 – via Newspapers.com.
Logan, Tim (3 April 2021). "Ginkgo Bioworks aims to keep growing with new building in Seaport". Boston Globe. p. D1. Retrieved 23 December 2022 – via Newspapers.com.

prnewswire.com

"Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform" (Press release). Ginkgo Bioworks. 6 June 2022. Retrieved 4 October 2022.

reuters.com

Spalding, Rebecca (9 October 2019). "Ginkgo Bioworks raises $350 million fund for biotech spinouts". Reuters. Archived from the original on 7 November 2019. Retrieved 7 November 2019.
Nishant, Niket (11 May 2021). "Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 billion deal". Reuters. Archived from the original on 11 May 2021. Retrieved 12 May 2021.
Jackson, Sierra (19 November 2021). "Biotech Ginkgo sued over revenue statements for $15 bln SPAC deal". Reuters. Retrieved 14 March 2024.

sec.gov

Ginkgo Bioworks Holdings, Inc. 2022 Annual Report (Form 10-K). U.S. Securities and Exchange Commission. 13 March 2023. pp. 31, F-4, F-5.

seekingalpha.com

Lokuwithana, Dulan (15 November 2021). "Ginkgo Bioworks says it received inquiry from DOJ after short seller report". SeekingAlpha. Retrieved 14 March 2024.

startupsavant.com

Price, Thomas (9 January 2021). "Startup Novogy Acquired by Ginkgo Bioworks". Archived from the original on 9 January 2021. Retrieved 21 December 2022.

technologyreview.com

Regalado, Antonio (24 August 2021). "Is Ginkgo's synthetic-biology story worth $15 billion?". MIT Technology Review. Retrieved 14 April 2024.

tipranks.com

"Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar" (Press release). Ginkgo Bioworks. 4 October 2022. Archived from the original on 4 October 2022. Retrieved 4 October 2022 – via TipRanks.
"Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy" (Press release). Ginkgo Bioworks. Archived from the original on 4 October 2022. Retrieved 2022-10-04 – via TipRanks.

web.archive.org

Molteni, Megan (14 September 2017). "With Designer Bacteria, Crops One Day Could Fertilize Themselves". Wired. Archived from the original on 5 December 2017. Retrieved 4 December 2017.
Herper, Mathew (8 June 2016). "Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry". Forbes. Archived from the original on 9 Jun 2016. Retrieved 4 December 2017.
Adams, Susan (14 September 2017). "Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer". Forbes. Archived from the original on 5 December 2017. Retrieved 4 December 2017.
Spalding, Rebecca (9 October 2019). "Ginkgo Bioworks raises $350 million fund for biotech spinouts". Reuters. Archived from the original on 7 November 2019. Retrieved 7 November 2019.
Weber, Joel (6 November 2019). "Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods". Bloomberg News. Archived from the original on 9 November 2019. Retrieved 7 November 2019.{{cite news}}: CS1 maint: bot: original URL status unknown (link)
de León, Riley (17 September 2021). "Ginkgo Bioworks begins trading on the NYSE after completing SPAC merger". CNBC. Archived from the original on 17 September 2021. Retrieved 17 September 2021.
Price, Thomas (9 January 2021). "Startup Novogy Acquired by Ginkgo Bioworks". Archived from the original on 9 January 2021. Retrieved 21 December 2022.
Nishant, Niket (11 May 2021). "Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 billion deal". Reuters. Archived from the original on 11 May 2021. Retrieved 12 May 2021.
"Taking Ginkgo Public on NYSE:DNA". Ginkgo Bioworks. 14 May 2021. Archived from the original on 15 May 2021. Retrieved 15 May 2021.
Pan, Eddie (7 April 2022). "Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here's Why". InvestorPlace. Archived from the original on 12 October 2022. Retrieved 21 December 2022.
"Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform" (Press release). Ginkgo Bioworks. Archived from the original on 4 October 2022. Retrieved 4 October 2022.
"Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities" (Press release). Bayer. Archived from the original on 5 October 2022. Retrieved 5 October 2022 – via Yahoo! Finance.
"Ginkgo Bioworks Acquires Adaptive Laboratory Evolution Company Altar" (Press release). Ginkgo Bioworks. 4 October 2022. Archived from the original on 4 October 2022. Retrieved 4 October 2022 – via TipRanks.
LeMieux, Julianna (5 October 2022). "Two Is Better Than One: Ginkgo Bioworks Acquires Altar and Circularis". Genetic Engineering and Biotechnology News. Archived from the original on 5 October 2022. Retrieved 5 October 2022.
"Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy" (Press release). Ginkgo Bioworks. Archived from the original on 4 October 2022. Retrieved 2022-10-04 – via TipRanks.

wired.com

Molteni, Megan (14 September 2017). "With Designer Bacteria, Crops One Day Could Fertilize Themselves". Wired. Archived from the original on 5 December 2017. Retrieved 4 December 2017.

yahoo.com

finance.yahoo.com

"Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform" (Press release). Ginkgo Bioworks. Archived from the original on 4 October 2022. Retrieved 4 October 2022.
"Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities" (Press release). Bayer. Archived from the original on 5 October 2022. Retrieved 5 October 2022 – via Yahoo! Finance.
https://finance.yahoo.com/quote/DNA/. {{cite web}}: Missing or empty |title= (help)